Literature DB >> 11367661

[Clinical observations on treatment of endometriosis by tonifying kidney and removing blood stasis].

J Liu1, X Li, X Hu.   

Abstract

OBJECTIVE: To explore the mechanism of treating endometriosis by tonifying Kidney and removing blood stasis with Neiyixiao Recipe (NYXR).
METHODS: One hundred and three patients of endometriosis were divided randomly into the NYXR group (58 cases, treated with NYXR) and the control group (45 cases, treated with danazol) and were reviewed for the improvement of clinical symptoms, serum level of FSH, LH, PRL, E2, P and T, humoral and cellular immunity (C3, C4, CD3, CD4, CD8), and plasma prostaglandin after treatment.
RESULTS: There was no significant difference in effect between the NYXR group and the control group in relief of dysmenorrhea and degradation of elevated plasma prostaglandin (chi 2 = 0.71, P > 0.05). But there was significant difference between the two groups in curing infertility (chi 2 = 14.77, P < 0.01), and the effect of NYXR in regulating endocrine and immunity was significantly better than that of danazol.
CONCLUSION: By tonifying Kidney and removing blood stasis, NYXR is multi-effective and being one of effective methods in clinical practice for treatment of endometriosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 11367661

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  2 in total

1.  Diagnostic Indicators for Blood Stasis Syndrome Patients with Gynaecological Diseases.

Authors:  Jeeyoun Jung; Mi Mi Ko; Myeong Soo Lee; So Min Lee; Ju Ah Lee
Journal:  Chin J Integr Med       Date:  2017-06-20       Impact factor: 1.978

Review 2.  Meta-Analysis of Chinese Traditional Medicine Bushen Huoxue Prescription for Endometriosis Treatment.

Authors:  Jing Shan; Wen Cheng; Dong-Xia Zhai; Dan-Ying Zhang; Rui-Pin Yao; Ling-Ling Bai; Zai-Long Cai; Yu-Huan Liu; Chao-Qin Yu
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-23       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.